NervGen Pharma Corp. Common stock (NGEN) Financials
NGEN Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 14.9 million | 10.9 million |
| Dec. 31, 2025 | 16.9 million | 14.4 million |
| Sept. 30, 2025 | 9.4 million | 11.5 million |
| June 30, 2025 | 12.4 million | 13.1 million |
NGEN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -6.0 million | ? |
| Dec. 31, 2025 | -7.4 million | 3.9 million |
| Sept. 30, 2025 | -3.8 million | 798862 |
| June 30, 2025 | -2.7 million | 1.5 million |
NGEN Net Income
No data available :(
NGEN Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 11.9 million | - | - |
| Dec. 31, 2025 | 16.1 million | - | 6104 |
| Sept. 30, 2025 | 8.2 million | - | 23861 |
| June 30, 2025 | 11.6 million | - | 42416 |
NGEN Shares Outstanding
NGEN Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 2 | 3.5 million | 1.9 million | - |
| Dec. 31, 2025 | - | 4.8 million | 3.8 million | - |
| Sept. 30, 2025 | - | 3.2 million | 1.2 million | - |
| June 30, 2025 | - | 2.0 million | 2.8 million | - |
NGEN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | - | 10169 |
| Dec. 31, 2025 | - | -21846 |
| Sept. 30, 2025 | - | 10015 |
| June 30, 2025 | - | 10244 |
NGEN
Price: $2
52 week price:
Earnings Per Share: -0.47 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 154.6 million